๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mo1924 Metabolic Syndrome in Liver Transplant Recipients and Their Risk of Major Cardiac Events

โœ Scribed by Singh, Gurshawn; Albeldawi, Mazen; Gupta, Vedant; Mehta, Paresh P.; Lopez, Rocio; Eghtesad, Bijan; Marwick, Thomas; Zein, Nizar N.


Book ID
122250732
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
114 KB
Volume
142
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Metabolic syndrome in liver transplant r
โœ Marie Laryea; Kymberly D. Watt; Michele Molinari; Mark J. Walsh; Vivian C. McAli ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 112 KB

Cardiac and cerebral vascular diseases are leading causes of morbidity and death in solid organ transplant recipients. Immunosuppressant drugs are associated with dyslipidemia, hypertension, and hyperglycemia, which along with obesity are the main features of metabolic syndrome. In the nontransplant

Metabolic syndrome in liver transplant r
โœ Ido Laish; Marius Braun; Eytan Mor; Jaqueline Sulkes; Yael Harif; Ziv Ben Ari ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 132 KB

Features of metabolic syndrome are not uncommon in patients after liver transplantation. To examine the prevalence and risk factors of posttransplantation metabolic syndrome (PTMS), the files of 252 transplant recipients (mean age, 54.5 6 2.8 years, 57.9% male) were reviewed for pretransplant and po